William Richard White, Chief Financial Officer at Akero Therapeutics, Inc. (AKRO), sold 5,634 shares at $30.79 ($173K) on 2024-12-10, disclosed to the SEC on 2024-12-12.
Seasonal sale ($173k) by Chief Financial Officer — this insider has traded AKRO in December in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.79 | 2,817 | $87K | 50.0% |
| 2 | $30.79 | 2,817 | $87K | 50.0% |
| Total | $30.79 avg | 5,634 | $173K | 100% |
| Filing → |
| AKRO | SELL | 2025-06-12 | $151K | — | Filing → |
| AKRO | SELL | 2025-03-14 | $30K | — | Filing → |
| IRON | SELL | 2024-12-04 | $240K | — | Filing → |